{"id":"https://openalex.org/W2012575151","doi":"https://doi.org/10.1097/00005344-198105000-00005","title":"Pharmacological Studies on Cadralazine","display_name":"Pharmacological Studies on Cadralazine","publication_year":1981,"publication_date":"1981-05-01","ids":{"openalex":"https://openalex.org/W2012575151","doi":"https://doi.org/10.1097/00005344-198105000-00005","mag":"2012575151","pmid":"https://pubmed.ncbi.nlm.nih.gov/6168827"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-198105000-00005","doi":"https://doi.org/10.1097/00005344-198105000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198105000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110078648","display_name":"Claudio Semeraro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Semeraro","raw_affiliation_strings":["ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038151196","display_name":"Luciano Dorigotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luciano Dorigotti","raw_affiliation_strings":["ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050523863","display_name":"Silvano Banfi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvano Banfi","raw_affiliation_strings":["ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111650970","display_name":"Carlo Carpi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlo Carpi","raw_affiliation_strings":["ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ISF Laboratories for Biomedical Research, Trezzano sul Naviglio, Milan, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2913,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.91046802,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":"3","first_page":"455","last_page":"467"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cadralazine","display_name":"cadralazine","score":1.0},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8270000219345093},{"id":"https://openalex.org/keywords/vasodilators","display_name":"vasodilators","score":0.9750000238418579},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7900000214576721},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.722000002861023},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.8090000152587891},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.8989999890327454},{"id":"https://openalex.org/keywords/renal-hypertension","display_name":"renal hypertension","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sympathetic-outflow","display_name":"sympathetic outflow","score":0.6679999828338623},{"id":"https://openalex.org/keywords/alpha-adrenergic-blockade","display_name":"alpha-adrenergic blockade","score":0.859000027179718},{"id":"https://openalex.org/keywords/acute-toxicity","display_name":"acute toxicity","score":0.6140000224113464},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2780521442","wikidata":"https://www.wikidata.org/wiki/Q419987","display_name":"Hydralazine","level":3,"score":0.8880115151405334},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.799102783203125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7672786712646484},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.6155178546905518},{"id":"https://openalex.org/C2779904517","wikidata":"https://www.wikidata.org/wiki/Q5008900","display_name":"CATS","level":2,"score":0.5967345237731934},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.5595486164093018},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5280126929283142},{"id":"https://openalex.org/C2775859304","wikidata":"https://www.wikidata.org/wiki/Q132621","display_name":"Epinephrine","level":2,"score":0.49531999230384827},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4801059067249298},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43968555331230164},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.409138947725296}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002415","descriptor_name":"Cats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004837","descriptor_name":"Epinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006830","descriptor_name":"Hydralazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-198105000-00005","doi":"https://doi.org/10.1097/00005344-198105000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198105000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:6168827","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6168827","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2408358355","https://openalex.org/W2426628064","https://openalex.org/W2465720003","https://openalex.org/W1965090053","https://openalex.org/W2468572945","https://openalex.org/W2022677929","https://openalex.org/W11828828","https://openalex.org/W2030847044","https://openalex.org/W2346464660","https://openalex.org/W2394886376"],"abstract_inverted_index":{"Cadralazine":[0,100,155],"is":[1,72],"a":[2,146,180],"new,":[3],"orally":[4],"effective":[5],"antihypertensive":[6,131],"vasodilator.":[7],"Acute":[8],"experiments":[9],"indicate":[10],"that":[11],"the":[12,69,78,116,130,184],"compound":[13],"reduces":[14,92],"blood":[15,26,93,119],"pressure":[16,27,94,120],"and":[17,36,77,110,136,163,179],"increases":[18],"heart":[19],"rate.":[20],"The":[21,113,138],"doses":[22],"which":[23],"reduce":[24],"systolic":[25],"by":[28,122,183],"25%":[29],"(ED25)":[30],"are":[31,142],"very":[32],"similar":[33],"after":[34,74],"oral":[35,86,185],"intravenous":[37],"administration":[38,87],"(spontaneously":[39],"hypertensive":[40,49,90,102],"rats,":[41],"1.8":[42],"mg/kg,":[43,46,52,55,61,64],"p.o.;":[44,53,62],"2.3":[45],"i.v.;":[47,56],"renal":[48],"dogs,":[50,59],"0.26":[51],"0.24":[54],"awake":[57,107],"normotensive":[58,108],"0.98":[60],"1.01":[63],"i.v.).":[65],"By":[66],"both":[67],"routes":[68],"peak":[70],"effect":[71,166],"reached":[73],"3-5":[75],"hr,":[76],"activity":[79,132,162,182],"lasts":[80],"more":[81],"than":[82],"24":[83],"hr.":[84],"Repeated":[85],"in":[88,106,118,126,133],"spontaneously":[89],"rats":[91,128],"with":[95,172],"no":[96,157,164],"evidence":[97],"of":[98,115,140,148],"tolerance.":[99],"reverses":[101],"responses":[103],"to":[104,145],"epinephrine":[105],"dogs":[109],"anesthetized":[111],"cats.":[112],"inhibition":[114],"increase":[117],"induced":[121],"sympathetic":[123,150],"outflow":[124],"activation":[125],"pithed":[127],"parallels":[129],"onset,":[134],"intensity,":[135],"duration.":[137],"effects":[139],"cadralazine":[141,174],"not":[143],"due":[144],"blockade":[147],"alpha-adrenoceptors,":[149],"neurons,":[151],"or":[152,160],"ganglionic":[153],"transmission.":[154],"has":[156,175],"antihistaminic,":[158],"anticholinergic,":[159],"spasmolytic":[161],"specific":[165],"on":[167],"behavioral":[168],"tests.":[169],"In":[170],"comparison":[171],"hydralazine,":[173],"less":[176],"acute":[177],"toxicity":[178],"greater":[181],"route.":[186]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}